Newsfeed : New Study Encourages Earlier HIV Treatment

POZ - Health, Life and HIV
Subscribe to:
POZ magazine
Join POZ: Facebook MySpace Twitter Pinterest
Tumblr Google+ Flickr MySpace
POZ Personals
Sign In / Join

Back to home » Newsfeed » April 2009

Most Popular Links
Most Popular Lessons

The HIV Life Cycle


Herpes Simplex Virus

Syphilis & Neurosyphilis

Treatments for Opportunistic Infections (OIs)

What is AIDS & HIV?

Hepatitis & HIV

20 Years Ago In POZ

More News

Click here for more news

Have news about HIV? Send press releases, news tips and other announcements to


April 30, 2009

New Study Encourages Earlier HIV Treatment

While national guidelines recommend that patients begin antiretroviral treatment when their CD4 count drops below 350, new research supports starting treatment far earlier, The New York Times reports.

“This has been one of the most important questions in the last decade: what the optimal timing is for starting therapy,” said study author Mari M. Kitahata, MD, director of clinical epidemiology at the Center for AIDS and STD at the University of Washington in Seattle. “Our study provides evidence that patients would live longer if antiretroviral treatment was begun when their CD4 count was above 500.”

According to the article, the study tracked the survival rates of 17,517 HIV-positive people in North America who began drug therapy at different points in disease progression, as measured by their CD4 counts. The study found that those who began treatment later faced a risk of dying that was up to 94 percent higher than those who initiated therapy early on.

The study, published April 30 in The New England Journal of Medicine, shares similar results with a separate study published online two weeks earlier in The Lancet.

Search: CD4, early treatment, Mari M. Kitahata, Center for AIDS and STD, University of Washington, North America

Scroll down to comment on this story.


(will display; 2-50 characters)


(will NOT display)


(will display; optional)

Comment (500 characters left):

(Note: The POZ team reviews all comments before they are posted. Please do not include either ":" or "@" in your comment. The opinions expressed by people providing comments are theirs alone. They do not necessarily reflect the opinions of Smart + Strong, which is not responsible for the accuracy of any of the information supplied by people providing comments.)

Comments require captcha.
Please enter this number for verification:

| Posting Rules

Show comments (1 total)

[Go to top]

Facebook Twitter Google+ MySpace YouTube Tumblr Flickr Instagram
Quick Links
Current Issue

HIV Testing
Safer Sex
Find a Date
Newly Diagnosed
HIV 101
Disclosing Your Status
Starting Treatment
Help Paying for Meds
Search for the Cure
POZ Stories
POZ Opinion
POZ Exclusives
Read the Blogs
Visit the Forums
Job Listings
Events Calendar
POZ on Twitter

Ask POZ Pharmacist

Talk to Us
Did you participate in an event for National Black HIV/AIDS Awareness Day 2016?


more surveys
Contact Us
We welcome your comments!
[ about Smart + Strong | about POZ | POZ advisory board | partner links | advertising policy | advertise/contact us | site map]
© 2016 Smart + Strong. All Rights Reserved. Terms of use and Your privacy.
Smart + Strong® is a registered trademark of CDM Publishing, LLC.